# One Touch® Verio®IQ European Clinical Outcomes Study

> **NCT01631643** · PHASE4 · WITHDRAWN · sponsor: **LifeScan**

## Conditions studied

- Diabetes

## Interventions

- **DEVICE:** One Touch VerioIQ Blood Glucose Monitor

## Key facts

- **NCT ID:** NCT01631643
- **Lead sponsor:** LifeScan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business decision to withdraw trial
- **Last updated:** 2012-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01631643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01631643, "One Touch® Verio®IQ European Clinical Outcomes Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01631643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*